Medicure Inc. (CVE:MPH – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$0.88 and traded as low as C$0.79. Medicure shares last traded at C$0.79, with a volume of 1,000 shares traded.
Medicure Price Performance
The firm has a 50-day moving average of C$0.79 and a 200-day moving average of C$0.88. The company has a debt-to-equity ratio of 4.65, a quick ratio of 1.29 and a current ratio of 2.03. The firm has a market capitalization of C$8.24 million, a P/E ratio of -4.05 and a beta of 0.90.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
See Also
- Five stocks we like better than Medicure
- What is the Dow Jones Industrial Average (DJIA)?
- MarketBeat Week in Review – 03/24 – 03/28
- Investing in Construction Stocks
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Airline Stocks – Top Airline Stocks to Buy Now
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
